A
Anavex Life Sciences Corp D
D
AVXL
3.71500
USD
-0.02
(-0.40%)
مغلق
حجم التداول
29,355
الربح لكل سهم
-1
العائد الربحي
-
P/E
-7
حجم السوق
331,928,218
الأخبار المقالات
العنوان: Anavex Life Sciences Corp
القطاع: Healthcare
الصناعة: Biotechnology
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer'sdisease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and severalother compounds in different stages of clinical and pre-clinical development.